/

Investors / United Kingdom / ALSA Ventures

ALSA Ventures

Venture capital · London, United Kingdom · Europe

alsaventures.com

ALSA Ventures is an international life science investor and biotechnology fund manager focused on novel therapeutics. It invests across the spectrum of drug development, from company formation to participating in syndicates with co-investors, and works with management teams on R&D execution.

Invests inHealthcare & Biotech

In its own wordsbiotechtherapeuticsdrug developmentlife sciencespharmaceuticals

Your fit with ALSA Ventures

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
7portfolio companies
0funding rounds on record

ALSA Ventures lists 7 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 60% of its companies are based in United Kingdom. It invests most often alongside AlbionVC, 3B Future Health Fund and BioGeneration Ventures.

No funding round on record names ALSA Ventures yet, so the figures come from its portfolio page.

Investor profile

percentile among all firms
Portfolio size: 7 companiesRecent activity: 0 rounds in 12 monthsEarly stage: 0% of entries at pre-seed or seedEvidence: 0% of companies confirmed by a roundSector focus: 100% in its largest sectorReach: 3 countriesPortfolio size12th pctRecent activity46th pctEarly stage54th pctEvidence52th pctSector focus100th pctReach58th pct
This firmMedian of all firms
Show as a table
ALSA Ventures compared with all firms
MeasurePercentile of all firmsValue
Portfolio size12th7 companies
Recent activity46th0 rounds in 12 months
Early stage54th0% of entries at pre-seed or seed
Evidence52th0% of companies confirmed by a round
Sector focus100th100% in its largest sector
Reach58th3 countries

Its portfolio companies

where they are based, and what their own sites show

Site status

  • Site answers7100%
  • No longer answers00%
  • Points to another company00%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech100%15%

Co-investor network

who it backs companies with, and who they back together
4 shared companies3 shared companies3 shared companies3 shared companies3 shared companies2 shared companies2 shared companies2 shared companies2 shared companiesAlbionVC: 2 shared companiesAlbionVC23B Future Health Fund: 1 shared companies3B Future Health Fund1BioGeneration Ventures: 1 shared companiesBioGeneration Ventures1Epidarex: 1 shared companiesEpidarex1Global BioAccess Fund: 1 shared companiesGlobal BioAccess Fund1Jeito Capital: 1 shared companiesJeito Capital1Novartis Venture Fund: 1 shared companiesNovartis Venture Fund1Ysios Capital: 1 shared companiesYsios Capital1
Shared portfolio companies with ALSA VenturesFirms that also back companies together

All co-investors or Compare portfolios with AlbionVC

Compare ALSA Ventures head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Portfolio

7 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Axovia Therapeuticsaxoviatherapeutics.comAxovia Therapeutics is developing treatments for genetic forms of obesity and blindness
Healthcare & Biotech
Portfolio page
Epsilogenepsilogen.com · United KingdomEpsilogen is a company that discovers and develops immunoglobulin IgE, IgA and IgG-based therapeutics for the treatment of cancer
Healthcare & Biotech
Portfolio page
Montis Biosciencesmontisbiosciences.com · BelgiumMontis Biosciences is a biotechnology company developing next-generation therapeutics that harness the dual biology of complement C1q
Healthcare & Biotech
Portfolio page
Oxford BioTherapeuticsoxfordbiotherapeutics.com · United KingdomOxford BioTherapeutics develops first-in-class cancer therapies through targeted therapies, including antibody-drug conjugates and immuno-oncology
Healthcare & Biotech
Portfolio page
Promatixpro-matix.comPromatix is developing innovative new classes of cancer therapies using bispecific antibodies.
Healthcare & Biotech
Portfolio page
ReproNovorepronovo.com · SwitzerlandReproNovo develops novel therapies for fertility and women’s health
Healthcare & Biotech
Portfolio page
Vantage Biosciencesvantage-biosciences.com · United KingdomVantage Biosciences is developing a novel, oral treatment for inflammatory conditions by targeting the root drivers of inflammation.
Healthcare & Biotech
Portfolio page

About this data

site last read 5 Nov 2026
The homepage of ALSA Ventures, as last read
alsaventures.com as VCinfo last read it
Site
alsaventures.com
Last read
5 Nov 2026
Watching since
5 Nov 2026
Companies checked
7

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get ALSA Ventures' profile as data

Pull ALSA Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/alsaventures.com

# also
GET /v1/firms/alsaventures.com/portfolio
GET /v1/firms/alsaventures.com/coinvestors
GET /v1/firms/alsaventures.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing